TXG Past Earnings Q&A
What was the best and worst TXG past earnings results?
For 10x Genomics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest TXG past earnings result in our data set was -0.070/share posted in Q4 2019, while the lowest was in Q3 2020 when TXG posted -0.650/share.
The biggest top line earnings performance — aka revenue — quarter was in Q4 2022 when TXG reported 0.16B in revenue, while the quarter with the lowest revenue in our data set was Q2 2020 at 0.04B of revenue.
There are 14 TXG past earnings results in our data set.
On this page we presented the TXG past earnings date information for 10x Genomics. Reviewing that
TXG Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q4 2019, when TXG posted gaap of -0.070/share. Meanwhile the lowest TXG past earnings result was in Q3 2020, when TXG posted gaap of -0.650/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2022 when TXG reported 0.16B in revenue, while the smallest revenue quarter was Q2 2020 when TXG reported 0.04B in revenue.
Any self directed investor doing their due diligence on TXG or any other given stock can benefit from
researching all of the 10x Genomics past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
10x Genomics past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for TXG. Thanks for visiting, and the next
time you need to research TXG past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.